Wikidata entity: Q64150116
Quantities
| P4135 | maximum age | 80 |
| P2899 | minimum age | 18 |
| P1132 | number of participants | 750 |
| P6099 | clinical trial phase | ... | Q42824827 (phase III clinical trial) | phase III clinical trial |
| P17 | country | ... | Q30 (United States) | United States |
| P582 | end time | ... | 2020-11-10 | ??? |
| P31 | instance of | ... | Q30612 (clinical trial) | clinical trial |
| P6153 | research site | ... | Q153265 (University of Cincinnati) | University of Cincinnati |
| P6153 | research site | ... | Q500606 (University of South Florida) | University of South Florida |
| P6153 | research site | ... | Q2471216 (Thomas Jefferson University) | Thomas Jefferson University |
| P6153 | research site | ... | Q2725999 (University of Texas Southwestern Medical Center) | University of Texas Southwestern Medical Center |
| P6153 | research site | ... | Q30269551 (Axiom Clinical Research of Florida) | Axiom Clinical Research of Florida |
| P6153 | research site | ... | Q30269570 (Alpine Clinical Research Center) | Alpine Clinical Research Center |
| P6153 | research site | ... | Q30269704 (Meridien Research) | Meridien Research |
| P6153 | research site | ... | Q30269903 (Heartland Research Associates) | Heartland Research Associates |
| P6153 | research site | ... | Q30269946 (Hillcrest Family Practice) | Hillcrest Family Practice |
| P6153 | research site | ... | Q30270033 (PMG Research) | PMG Research |
| P6153 | research site | ... | Q30270193 (Meridian Clinical Research) | Meridian Clinical Research |
| P6153 | research site | ... | Q30270668 (Westside Center for Clinical Research) | Westside Center for Clinical Research |
| P6153 | research site | ... | Q30282378 (Northwest Clinical Research Center) | Northwest Clinical Research Center |
| P6153 | research site | ... | Q50035554 (Pharmacology Research Institute) | Pharmacology Research Institute |
| P6153 | research site | ... | Q50039536 (Colorado Springs Neurological Associates) | Colorado Springs Neurological Associates |
| P580 | start time | ... | 2019-05-06 | ??? |
| P8363 | study type | ... | Q78089383 (interventional study) | interventional study |
| P1476 | title | Monolingualtext | A Phase 3, Multicenter, Open-Label 40-week Extension Study to Evaluate the Long-Term Safety and Tolerability of Oral Atogepant for the Prevention of Migraine in Participants With Episodic Migraine | ??? |
| P3098 | ClinicalTrials.gov ID | NCT03939312 |
Why not click here or view trends?
log id: 4719903